Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects.
Antimicrob Agents Chemother
; 62(4)2018 04.
Article
in En
| MEDLINE
| ID: mdl-29311094
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lipoglycopeptides
/
Aminoglycosides
/
Anti-Bacterial Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2018
Type:
Article
Affiliation country:
United States